Filing Details
- Accession Number:
- 0001127602-13-010432
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-03-12 14:22:34
- Reporting Period:
- 2013-03-11
- Filing Date:
- 2013-03-12
- Accepted Time:
- 2013-03-12 14:22:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875045 | Biogen Idec Inc. | BIIB | Biological Products, (No Disgnostic Substances) (2836) | 330112644 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1202098 | Stelios Papadopoulos | Biogen Idec Inc. 133 Boston Post Road Weston MA 02493 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-03-11 | 35,000 | $59.17 | 49,950 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-03-11 | 31,034 | $172.08 | 18,916 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2013-03-11 | 3,966 | $172.72 | 14,950 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2013-03-11 | 5,700 | $59.17 | 20,650 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-03-11 | 5,700 | $172.45 | 14,950 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2013-03-11 | 5,975 | $53.43 | 20,925 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-03-11 | 5,975 | $172.67 | 14,950 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2013-03-11 | 35,000 | $0.00 | 35,000 | $59.17 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2013-03-11 | 5,700 | $0.00 | 5,700 | $59.17 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2013-03-11 | 5,975 | $0.00 | 5,975 | $53.43 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2018-06-18 | No | 4 | M | Direct | |
| 0 | 2009-06-19 | 2018-06-18 | No | 4 | M | Direct |
| 0 | 2010-06-03 | 2019-06-02 | No | 4 | M | Direct |
Footnotes
- Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
- Full information regarding the number of shares sold at each separate price will be provided upon request by the SEC staff, the issuer, or a security holder of the issuer.
- This represents the weighted average price for shares sold at a range between $171.68 (low) and $172.68 (high).
- This represents the weighted average price for shares sold at a range between $172.68 (low) and $172.79 (high).
- This represents the weighted average price for shares sold at a range between $171.80 (low) and $172.75 (high).
- This represents the weighted average price for shares sold at a range between $172.59 (low) and $172.75 (high).
- Granted under one of the Issuer's stock option plans, in an exempt transaction under SEC Rule 16(b)-3(d).
- The stock options become exercisable in three (3) equal annual installments, commencing one year after the grant date of 06/19/2008.
Billionaire Hedge Funds
